{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:40:07Z","timestamp":1789587607513,"version":"build-2803163510"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1476-4598-13-191","type":"journal-article","created":{"date-parts":[[2014,8,13]],"date-time":"2014-08-13T13:14:50Z","timestamp":1407935690000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":91,"title":["OX26\/CTX-conjugated PEGylated liposome as a dual-targeting gene delivery system for brain glioma"],"prefix":"10.1186","volume":"13","author":[{"given":"Pei-jian","family":"Yue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-wei","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-ji","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-pen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,8,13]]},"reference":[{"key":"1390_CR1","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1016\/S0140-6736(11)61346-9","volume":"379","author":"D Ricard","year":"2012","unstructured":"Ricard D, Idbaih A, Ducray F, Lahutte M, Hoang-Xuan K, Delattre JY: Primary brain tumours in adults. Lancet. 2012, 379: 1984-1996.","journal-title":"Lancet"},{"key":"1390_CR2","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","volume":"114","author":"DN Louis","year":"2007","unstructured":"Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P: The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007, 114: 97-109.","journal-title":"Acta Neuropathol"},{"key":"1390_CR3","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S1359-6446(01)01721-4","volume":"6","author":"WM Pardridge","year":"2001","unstructured":"Pardridge WM: BBB-genomics: creating new openings for brain-drug targeting. Drug Discov Today. 2001, 6: 381-383.","journal-title":"Drug Discov Today"},{"key":"1390_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pharmthera.2010.04.015","volume":"128","author":"L Arko","year":"2010","unstructured":"Arko L, Katsyv I, Park GE, Luan WP, Park JK: Experimental approaches for the treatment of malignant gliomas. Pharmacol Ther. 2010, 128: 1-36.","journal-title":"Pharmacol Ther"},{"key":"1390_CR5","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","volume":"10","author":"R Stupp","year":"2009","unstructured":"Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K, Hau P, Brandes AA, Gijtenbeek J, Marosi C, Vecht CJ, Mokhtari K, Wesseling P, Villa S, Eisenhauer E, Gorlia T, Weller M, Lacombe D, Cairncross JG, Mirimanoff RO: Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009, 10: 459-466.","journal-title":"Lancet Oncol"},{"key":"1390_CR6","doi-asserted-by":"publisher","first-page":"14164","DOI":"10.1073\/pnas.93.24.14164","volume":"93","author":"J Huwyler","year":"1996","unstructured":"Huwyler J, Wu D, Pardridge WM: Brain drug delivery of small molecules using immunoliposomes. Proc Natl Acad Sci U S A. 1996, 93: 14164-14169.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1390_CR7","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1007\/s11095-010-0110-1","volume":"27","author":"AS Abu Lila","year":"2010","unstructured":"Abu Lila AS, Ishida T, Kiwada H: Targeting anticancer drugs to tumor vasculature using cationic liposomes. Pharm Res. 2010, 27: 1171-1183.","journal-title":"Pharm Res"},{"key":"1390_CR8","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/S0163-7827(03)00032-8","volume":"42","author":"P Sapra","year":"2003","unstructured":"Sapra P, Allen TM: Ligand-targeted liposomal anticancer drugs. Prog Lipid Res. 2003, 42: 439-462.","journal-title":"Prog Lipid Res"},{"key":"1390_CR9","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jconrel.2006.11.028","volume":"118","author":"Y Hu","year":"2007","unstructured":"Hu Y, Xie J, Tong YW, Wang CH: Effect of PEG conformation and particle size on the cellular uptake efficiency of nanoparticles with the HepG2 cells. J Control Release. 2007, 118: 7-17.","journal-title":"J Control Release"},{"key":"1390_CR10","first-page":"1172","volume":"8","author":"JW Park","year":"2002","unstructured":"Park JW, Hong K, Kirpotin DB, Colbern G, Shalaby R, Baselga J, Shao Y, Nielsen UB, Marks JD, Moore D, Papahadjopoulos D, Benz CC: Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery. Clin Cancer Res. 2002, 8: 1172-1181.","journal-title":"Clin Cancer Res"},{"key":"1390_CR11","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1126\/science.1095833","volume":"303","author":"TM Allen","year":"2004","unstructured":"Allen TM, Cullis PR: Drug delivery systems: entering the mainstream. Science. 2004, 303: 1818-1822.","journal-title":"Science"},{"key":"1390_CR12","first-page":"3991","volume":"8","author":"R Mukthavaram","year":"2013","unstructured":"Mukthavaram R, Jiang P, Saklecha R, Simberg D, Bharati IS, Nomura N, Chao Y, Pastorino S, Pingle SC, Fogal V, Wrasidlo W, Makale M, Kesari S: High-efficiency liposomal encapsulation of a tyrosine kinase inhibitor leads to improved in vivo toxicity and tumor response profile. Int J Nanomedicine. 2013, 8: 3991-4006.","journal-title":"Int J Nanomedicine"},{"key":"1390_CR13","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1023\/A:1010910523202","volume":"18","author":"N Shi","year":"2001","unstructured":"Shi N, Boado RJ, Pardridge WM: Receptor-mediated gene targeting to tissues in vivo following intravenous administration of pegylated immunoliposomes. Pharm Res. 2001, 18: 1091-1095.","journal-title":"Pharm Res"},{"key":"1390_CR14","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jconrel.2009.09.020","volume":"141","author":"X Ying","year":"2010","unstructured":"Ying X, Wen H, Lu WL, Du J, Guo J, Tian W, Men Y, Zhang Y, Li RJ, Yang TY, Shang DW, Lou JN, Zhang LR, Zhang Q: Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals. J Control Release. 2010, 141: 183-192.","journal-title":"J Control Release"},{"key":"1390_CR15","doi-asserted-by":"publisher","first-page":"3324","DOI":"10.1016\/j.biomaterials.2012.01.025","volume":"33","author":"J Ren","year":"2012","unstructured":"Ren J, Shen S, Wang D, Xi Z, Guo L, Pang Z, Qian Y, Sun X, Jiang X: The targeted delivery of anticancer drugs to brain glioma by PEGylated oxidized multi-walled carbon nanotubes modified with angiopep-2. Biomaterials. 2012, 33: 3324-3333.","journal-title":"Biomaterials"},{"key":"1390_CR16","doi-asserted-by":"publisher","first-page":"4014","DOI":"10.1016\/j.biomaterials.2009.04.011","volume":"30","author":"B Liang","year":"2009","unstructured":"Liang B, He ML, Chan CY, Chen YC, Li XP, Li Y, Zheng D, Lin MC, Kung HF, Shuai XT, Peng Y: The use of folate-PEG-grafted-hybranched-PEI nonviral vector for the inhibition of glioma growth in the rat. Biomaterials. 2009, 30: 4014-4020.","journal-title":"Biomaterials"},{"key":"1390_CR17","doi-asserted-by":"publisher","first-page":"7567","DOI":"10.1073\/pnas.130187497","volume":"97","author":"N Shi","year":"2000","unstructured":"Shi N, Pardridge WM: Noninvasive gene targeting to the brain. Proc Natl Acad Sci U S A. 2000, 97: 7567-7572.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1390_CR18","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/jgm.255","volume":"4","author":"Y Zhang","year":"2002","unstructured":"Zhang Y, Jeong Lee H, Boado RJ, Pardridge WM: Receptor-mediated delivery of an antisense gene to human brain cancer cells. J Gene Med. 2002, 4: 183-194.","journal-title":"J Gene Med"},{"key":"1390_CR19","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0022-3565(25)20567-5","volume":"259","author":"WM Pardridge","year":"1991","unstructured":"Pardridge WM, Buciak JL, Friden PM: Selective transport of an anti-transferrin receptor antibody through the blood\u2013brain barrier in vivo. J Pharmacol Exp Ther. 1991, 259: 66-70.","journal-title":"J Pharmacol Exp Ther"},{"key":"1390_CR20","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/312162a0","volume":"312","author":"WA Jefferies","year":"1984","unstructured":"Jefferies WA, Brandon MR, Hunt SV, Williams AF, Gatter KC, Mason DY: Transferrin receptor on endothelium of brain capillaries. Nature. 1984, 312: 162-163.","journal-title":"Nature"},{"key":"1390_CR21","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1080\/10611860290022679","volume":"10","author":"D Wu","year":"2002","unstructured":"Wu D, Song BW, Vinters HV, Pardridge WM: Pharmacokinetics and brain uptake of biotinylated basic fibroblast growth factor conjugated to a blood\u2013brain barrier drug delivery system. J Drug Target. 2002, 10: 239-245.","journal-title":"J Drug Target"},{"key":"1390_CR22","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jconrel.2008.10.006","volume":"133","author":"DJ Yoon","year":"2009","unstructured":"Yoon DJ, Chu DS, Ng CW, Pham EA, Mason AB, Hudson DM, Smith VC, MacGillivray RT, Kamei DT: Genetically engineering transferrin to improve its in vitro ability to deliver cytotoxins. J Control Release. 2009, 133: 178-184.","journal-title":"J Control Release"},{"key":"1390_CR23","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.1074\/jbc.M205662200","volume":"278","author":"J Deshane","year":"2003","unstructured":"Deshane J, Garner CC, Sontheimer H: Chlorotoxin inhibits glioma cell invasion via matrix metalloproteinase-2. J Biol Chem. 2003, 278: 4135-4144.","journal-title":"J Biol Chem"},{"key":"1390_CR24","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1002\/glia.10083","volume":"39","author":"SA Lyons","year":"2002","unstructured":"Lyons SA, O\u2019Neal J, Sontheimer H: Chlorotoxin, a scorpion-derived peptide, specifically binds to gliomas and tumors of neuroectodermal origin. Glia. 2002, 39: 162-173.","journal-title":"Glia"},{"key":"1390_CR25","doi-asserted-by":"publisher","first-page":"6882","DOI":"10.1158\/0008-5472.CAN-06-3948","volume":"67","author":"M Veiseh","year":"2007","unstructured":"Veiseh M, Gabikian P, Bahrami SB, Veiseh O, Zhang M, Hackman RC, Ravanpay AC, Stroud MR, Kusuma Y, Hansen SJ, Kwok D, Munoz NM, Sze RW, Grady WM, Greenberg NM, Ellenbogen RG, Olson JM: Tumor paint: a chlorotoxin:Cy5.5 bioconjugate for intraoperative visualization of cancer foci. Cancer Res. 2007, 67: 6882-6888.","journal-title":"Cancer Res"},{"key":"1390_CR26","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1002\/smll.200700784","volume":"4","author":"C Sun","year":"2008","unstructured":"Sun C, Veiseh O, Gunn J, Fang C, Hansen S, Lee D, Sze R, Ellenbogen RG, Olson J, Zhang M: In vivo MRI detection of gliomas by chlorotoxin-conjugated superparamagnetic nanoprobes. Small. 2008, 4: 372-379.","journal-title":"Small"},{"key":"1390_CR27","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.biomaterials.2008.10.003","volume":"30","author":"O Veiseh","year":"2009","unstructured":"Veiseh O, Kievit FM, Gunn JW, Ratner BD, Zhang M: A ligand-mediated nanovector for targeted gene delivery and transfection in cancer cells. Biomaterials. 2009, 30: 649-657.","journal-title":"Biomaterials"},{"key":"1390_CR28","first-page":"3226","volume":"62","author":"JJ Huang","year":"2002","unstructured":"Huang JJ, Lin MC, Bai YX, Jing DD, Wong BC, Han SW, Lin J, Xu B, Huang CF, Kung HF: Ectopic expression of a COOH-terminal fragment of the human telomerase reverse transcriptase leads to telomere dysfunction and reduction of growth and tumorigenicity in HeLa cells. Cancer Res. 2002, 62: 3226-3232.","journal-title":"Cancer Res"},{"key":"1390_CR29","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1093\/hmg\/10.7.677","volume":"10","author":"JW Shay","year":"2001","unstructured":"Shay JW, Zou Y, Hiyama E, Wright WE: Telomerase and cancer. Hum Mol Genet. 2001, 10: 677-685.","journal-title":"Hum Mol Genet"},{"key":"1390_CR30","first-page":"1","volume":"3","author":"LF Huo","year":"2006","unstructured":"Huo LF, Tang JW, Huang JJ, Huang PT, Huang CF, Kung HF, Lin MC: Cancer immunotherapy targeting the telomerase reverse transcriptase. Cell Mol Immunol. 2006, 3: 1-11.","journal-title":"Cell Mol Immunol"},{"key":"1390_CR31","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.drudis.2006.10.013","volume":"12","author":"WM Pardridge","year":"2007","unstructured":"Pardridge WM: Blood\u2013brain barrier delivery. Drug Discov Today. 2007, 12: 54-61.","journal-title":"Drug Discov Today"},{"key":"1390_CR32","doi-asserted-by":"publisher","first-page":"5628","DOI":"10.1016\/j.biomaterials.2013.03.097","volume":"34","author":"JQ Gao","year":"2013","unstructured":"Gao JQ, Lv Q, Li LM, Tang XJ, Li FZ, Hu YL, Han M: Glioma targeting and blood\u2013brain barrier penetration by dual-targeting doxorubincin liposomes. Biomaterials. 2013, 34: 5628-5639.","journal-title":"Biomaterials"},{"key":"1390_CR33","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.jconrel.2012.01.031","volume":"159","author":"P Zhang","year":"2012","unstructured":"Zhang P, Hu L, Yin Q, Zhang Z, Feng L, Li Y: Transferrin-conjugated polyphosphoester hybrid micelle loading paclitaxel for brain-targeting delivery: synthesis, preparation and in vivo evaluation. J Control Release. 2012, 159: 429-434.","journal-title":"J Control Release"},{"key":"1390_CR34","doi-asserted-by":"publisher","first-page":"6898","DOI":"10.1016\/j.biomaterials.2012.06.050","volume":"33","author":"K Shao","year":"2012","unstructured":"Shao K, Wu J, Chen Z, Huang S, Li J, Ye L, Lou J, Zhu L, Jiang C: A brain-vectored angiopep-2 based polymeric micelles for the treatment of intracranial fungal infection. Biomaterials. 2012, 33: 6898-6907.","journal-title":"Biomaterials"},{"key":"1390_CR35","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jconrel.2007.12.018","volume":"127","author":"IP Kaur","year":"2008","unstructured":"Kaur IP, Bhandari R, Bhandari S, Kakkar V: Potential of solid lipid nanoparticles in brain targeting. J Control Release. 2008, 127: 97-109.","journal-title":"J Control Release"},{"key":"1390_CR36","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ijpharm.2011.07.021","volume":"419","author":"Y Qin","year":"2011","unstructured":"Qin Y, Chen H, Yuan W, Kuai R, Zhang Q, Xie F, Zhang L, Zhang Z, Liu J, He Q: Liposome formulated with TAT-modified cholesterol for enhancing the brain delivery. Int J Pharm. 2011, 419: 85-95.","journal-title":"Int J Pharm"},{"key":"1390_CR37","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1021\/mp800049w","volume":"5","author":"SD Li","year":"2008","unstructured":"Li SD, Huang L: Pharmacokinetics and biodistribution of nanoparticles. Mol Pharm. 2008, 5: 496-504.","journal-title":"Mol Pharm"},{"key":"1390_CR38","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1517\/17425247.2.2.237","volume":"2","author":"S Simoes","year":"2005","unstructured":"Simoes S, Filipe A, Faneca H, Mano M, Penacho N, Duzgunes N, de Lima MP: Cationic liposomes for gene delivery. Expert Opin Drug Deliv. 2005, 2: 237-254.","journal-title":"Expert Opin Drug Deliv"},{"key":"1390_CR39","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.addr.2004.12.004","volume":"57","author":"JS Zhang","year":"2005","unstructured":"Zhang JS, Liu F, Huang L: Implications of pharmacokinetic behavior of lipoplex for its inflammatory toxicity. Adv Drug Deliv Rev. 2005, 57: 689-698.","journal-title":"Adv Drug Deliv Rev"},{"key":"1390_CR40","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.ejpb.2008.08.021","volume":"71","author":"K Ulbrich","year":"2009","unstructured":"Ulbrich K, Hekmatara T, Herbert E, Kreuter J: Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood\u2013brain barrier (BBB). Eur J Pharm Biopharm. 2009, 71: 251-256.","journal-title":"Eur J Pharm Biopharm"},{"key":"1390_CR41","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1021\/mp800218q","volume":"6","author":"J Du","year":"2009","unstructured":"Du J, Lu WL, Ying X, Liu Y, Du P, Tian W, Men Y, Guo J, Zhang Y, Li RJ, Zhou J, Lou JN, Wang JC, Zhang X, Zhang Q: Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood\u2013brain barrier and survival of brain tumor-bearing animals. Mol Pharm. 2009, 6: 905-917.","journal-title":"Mol Pharm"},{"key":"1390_CR42","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0378-5173(03)00269-2","volume":"261","author":"S Jain","year":"2003","unstructured":"Jain S, Mishra V, Singh P, Dubey PK, Saraf DK, Vyas SP: RGD-anchored magnetic liposomes for monocytes\/neutrophils-mediated brain targeting. Int J Pharm. 2003, 261: 43-55.","journal-title":"Int J Pharm"},{"key":"1390_CR43","doi-asserted-by":"publisher","first-page":"4194","DOI":"10.1073\/pnas.75.9.4194","volume":"75","author":"F Szoka Jr","year":"1978","unstructured":"Szoka F, Papahadjopoulos D: Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. Proc Natl Acad Sci U S A. 1978, 75: 4194-4198.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1390_CR44","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ijpharm.2012.05.041","volume":"434","author":"S Yang","year":"2012","unstructured":"Yang S, Chen J, Zhao D, Han D, Chen X: Comparative study on preparative methods of DC-Chol\/DOPE liposomes and formulation optimization by determining encapsulation efficiency. Int J Pharm. 2012, 434: 155-160.","journal-title":"Int J Pharm"},{"key":"1390_CR45","doi-asserted-by":"publisher","first-page":"12754","DOI":"10.1073\/pnas.221450098","volume":"98","author":"N Shi","year":"2001","unstructured":"Shi N, Zhang Y, Zhu C, Boado RJ, Pardridge WM: Brain-specific expression of an exogenous gene after i.v. administration. Proc Natl Acad Sci U S A. 2001, 98: 12754-12759.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1390_CR46","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jconrel.2008.03.007","volume":"128","author":"Z Pang","year":"2008","unstructured":"Pang Z, Lu W, Gao H, Hu K, Chen J, Zhang C, Gao X, Jiang X, Zhu C: Preparation and brain delivery property of biodegradable polymersomes conjugated with OX26. J Control Release. 2008, 128: 120-127.","journal-title":"J Control Release"},{"key":"1390_CR47","doi-asserted-by":"crossref","first-page":"850","DOI":"10.2144\/03344pt03","volume":"34","author":"LJ Jones","year":"2003","unstructured":"Jones LJ, Haugland RP, Singer VL: Development and characterization of the NanoOrange protein quantitation assay: a fluorescence-based assay of proteins in solution. Biotechniques. 2003, 34: 850-854. 856, 858 passim","journal-title":"Biotechniques"},{"key":"1390_CR48","doi-asserted-by":"publisher","first-page":"4293","DOI":"10.1016\/j.biomaterials.2011.02.044","volume":"32","author":"H Xin","year":"2011","unstructured":"Xin H, Jiang X, Gu J, Sha X, Chen L, Law K, Chen Y, Wang X, Jiang Y, Fang X: Angiopep-conjugated poly(ethylene glycol)-co-poly(epsilon-caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma. Biomaterials. 2011, 32: 4293-4305.","journal-title":"Biomaterials"},{"key":"1390_CR49","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s11095-006-9224-x","volume":"24","author":"V Rivest","year":"2007","unstructured":"Rivest V, Phivilay A, Julien C, Belanger S, Tremblay C, Emond V, Calon F: Novel liposomal formulation for targeted gene delivery. Pharm Res. 2007, 24: 981-990.","journal-title":"Pharm Res"},{"key":"1390_CR50","doi-asserted-by":"publisher","first-page":"3899","DOI":"10.1016\/j.biomaterials.2012.02.004","volume":"33","author":"Y Li","year":"2012","unstructured":"Li Y, He H, Jia X, Lu WL, Lou J, Wei Y: A dual-targeting nanocarrier based on poly(amidoamine) dendrimers conjugated with transferrin and tamoxifen for treating brain gliomas. Biomaterials. 2012, 33: 3899-3908.","journal-title":"Biomaterials"},{"key":"1390_CR51","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1016\/j.biomaterials.2012.11.050","volume":"34","author":"Y Qian","year":"2013","unstructured":"Qian Y, Zha Y, Feng B, Pang Z, Zhang B, Sun X, Ren J, Zhang C, Shao X, Zhang Q, Jiang X: PEGylated poly(2-(dimethylamino) ethyl methacrylate)\/DNA polyplex micelles decorated with phage-displayed TGN peptide for brain-targeted gene delivery. Biomaterials. 2013, 34: 2117-2129.","journal-title":"Biomaterials"},{"key":"1390_CR52","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1111\/j.1349-7006.2010.01560.x","volume":"101","author":"MY Cai","year":"2010","unstructured":"Cai MY, Zhang B, He WP, Yang GF, Rao HL, Rao ZY, Wu QL, Guan XY, Kung HF, Zeng YX, Xie D: Decreased expression of PinX1 protein is correlated with tumor development and is a new independent poor prognostic factor in ovarian carcinoma. Cancer Sci. 2010, 101: 1543-1549.","journal-title":"Cancer Sci"},{"key":"1390_CR53","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.ygyno.2005.04.035","volume":"98","author":"H Brustmann","year":"2005","unstructured":"Brustmann H: Immunohistochemical detection of human telomerase reverse transcriptase (hTERT) and c-kit in serous ovarian carcinoma: a clinicopathologic study. Gynecol Oncol. 2005, 98: 396-402.","journal-title":"Gynecol Oncol"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1476-4598-13-191.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T01:12:14Z","timestamp":1746321134000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/1476-4598-13-191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,13]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["1390"],"URL":"https:\/\/doi.org\/10.1186\/1476-4598-13-191","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,13]]},"assertion":[{"value":"18 January 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"191"}}